Downregulating PRMT5 or inhibiting its activity can specifically disrupt the intron-removal process during mRNA precursor processing, leading to the degradation of genes related to the cell cycle and proliferation and thereby counteracting tumor growth. Here, PRMT5 is linked to neoplasm.